Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

DARK SECRETS: Acutus medical s return on capital employed overview - The Real Truth

Benzinga Pro data, Acutus Medical (NASDAQ:AFIB) reported Q1 sales of $3.68 million. Earnings fell to a loss of $40.02 million, resulting in a 28.0% decrease from last quarter. Acutus Medical collected $4.36 million in revenue during Q4, but reported earnings showed a $31.26 million loss.

What Is Return On Capital Employed?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.